Related Experiment Video
Updated: Feb 13, 2026
Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
Published on: April 15, 2022
Novel Treatments for Multiple Myeloma: What Role Do They Have in Older Adults?
1McMaster University, Hamilton, ON, Canada.
Abstract:
Multiple myeloma is a malignant plasma cell disease, which typically affects older patients, with a median age at diagnosis of 70 years. The recent introduction of novel drugs and ongoing improvements in supportive care have significantly contributed to overall better management and outcomes for patients with multiple myeloma. Autologous stem-cell transplantation has been a standard part of therapy for myeloma patients for many years, first in younger patients and increasingly in older, and may still be considered in selected older patients with myeloma. In addition, in both newly diagnosed patients and in the relapsed/refractory setting, a number of novel agents tested in large phase III trials have yielded improvements in overall outcomes. As clinical trials under-enrol older patients and have stringent exclusion criteria, the data and results from them may not be generalizable to all older adults. In this review, we examine the treatment options for older adults with myeloma with a specific focus on the currently available data on novel agents in this cohort. The clinical efficacy and unique toxicity profile of each novel agent must be considered prior to the treatment plan in older adults.
Insights
Novel drugs and supportive care improve outcomes for older adults with multiple myeloma. This review focuses on novel agents, considering their efficacy and toxicity in this specific patient population.
Area of Science:
- Hematology
- Oncology
- Geriatric Medicine
Background:
- Multiple myeloma is a plasma cell malignancy predominantly affecting older adults (median age 70).
- Advances in novel drugs and supportive care have improved patient management and outcomes.
- Autologous stem-cell transplantation remains a consideration for select older myeloma patients.
Purpose of the Study:
- To review treatment options for older adults with multiple myeloma.
- To focus on the efficacy and toxicity of novel agents in this geriatric cohort.
- To address the generalizability of clinical trial data to older adults.
Main Methods:
- Literature review of clinical trials and relevant studies.
- Focus on data pertaining to older adult populations with multiple myeloma.
- Analysis of novel agents, including efficacy and toxicity profiles.
Main Results:
- Novel agents have demonstrated improved outcomes in both newly diagnosed and relapsed/refractory multiple myeloma.
- Clinical trial data may not fully represent the older adult population due to under-enrollment and exclusion criteria.
- Individualized treatment plans are crucial, considering the unique efficacy and toxicity of each novel agent.
Conclusions:
- Older adults with multiple myeloma benefit from novel drugs and supportive care advancements.
- Careful consideration of novel agent efficacy and toxicity is essential for treatment planning in older patients.
- Further research is needed to ensure clinical trial data is generalizable to diverse older adult populations.
More Related Videos
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
Related Concept Videos
01:49Multiple Allele Traits
01:33Adult Stem Cells
01:02Role of Septins
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...
01:25Multiple Regression
Farmers can use multiple regression to determine the crop yield based on more than one factor, such as water availability, fertilizer, soil properties, etc. Here, the crop yield is the response or dependent variable as it depends on the other independent variables. The analysis requires the construction of a scatter plot...
01:23The Role of Culture
01:21Role-Based Identity